MannKind Corp
MNKD
#5812
Rank
A$1.81 B
Marketcap
A$5.66
Share price
3.72%
Change (1 day)
-32.16%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): A-$0.29

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is A-$0.19. In 2022 the company made an earnings per share (EPS) of A-$0.49 a decrease over its 2021 EPS that were of A-$0.46.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$0.29-42.04%
2022A-$0.496.25%
2021A-$0.4628%
2020A-$0.36-7.41%
2019A-$0.39-55.74%
2018A-$0.88-45.05%
2017A-$1.61-188.1%
2016A$1.83-128.31%
2015A-$6.4674.51%
2014A-$3.70-20.31%
2013A-$4.64-32.63%
2012A-$6.89-28.03%
2011A-$9.58-12%
2010A-$10.88-27.54%
2009A-$15.02-30.3%
2008A-$21.54-18.85%
2007A-$26.55-19.03%
2006A-$32.7956.94%
2005A-$20.89-21.74%
2004A-$26.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.10-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$5.92-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$44.78-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.44-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$5.11-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$4.29 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA